What are the risks of implementing interoperability in nonstandard ways for electronic health information access?

Where nonstandard interoperability becomes a governance problem

Interoperability in healthcare is not just a technical routing choice, because the way systems expose, request, and return electronic health information shapes who can reliably access it, how consistently it is presented, and whether transfers work across boundaries. When an implementation departs from common patterns, the burden shifts to patients, providers, and support teams to interpret differences that should have been invisible.

That is why nonstandard implementations tend to create uneven access experiences. One portal may expose a record cleanly while another requires extra steps, partial exports, or workarounds, which can look like simple integration friction but often becomes a governance issue once it affects continuity of care or fair access.

Why nonstandard designs raise operational and compliance risk

Nonstandard interoperability increases the chance that the same data will behave differently depending on the vendor, workflow, or endpoint involved. That inconsistency can complicate testing, break downstream integrations, and make it harder to prove that information is available on the same terms across systems. The result is not only more support effort, but a higher likelihood of information blocking concerns when patients or other authorised users cannot obtain electronic health information through ordinary channels.

For healthcare organisations, the practical risk is that an unusual design choice becomes an access control problem by another name. Exports may be incomplete, transitions between systems may require manual intervention, and every exception adds another place where policy, workflow, or vendor behaviour can diverge from the intended standard.

Security and compliance teams should also notice that nonstandard patterns make it harder to compare implementations across environments. A control that works in one application may fail silently in another, especially when interface behaviour, data mapping, or export rules differ in subtle ways. That kind of variability weakens assurance even when no single system appears obviously broken.

What practitioners should verify before accepting a custom approach

Before approving a nonstandard design, verify whether the deviation is genuinely required or merely convenient. If the answer is convenience, the design should be treated as higher risk because it usually increases long-term support costs without improving the patient or provider experience. Where a deviation is unavoidable, define exactly what data moves, who can trigger it, and how success is measured.

It is also worth checking whether the implementation still preserves portability between systems. A custom pathway that works inside one platform but fails during a transfer, merger, or vendor change can create hidden lock-in. That matters because health information access is expected to survive operational change, not depend on one workflow remaining untouched forever.

Practitioners should confirm that exports, transitions, and user-facing access paths are tested under real-world conditions, not only in the happy path. In practice, many interoperability failures appear first when data volume, edge-case records, or exception handling are involved. The safer design is the one that still behaves predictably when the patient record, destination system, or requesting workflow is not perfectly ordinary.

Risk and Threat Considerations

Nonstandard interoperability creates a larger attack and failure surface because unusual workflows are harder to understand, test, and monitor consistently. That can expose gaps in data availability, increase the chance of misrouting or incomplete export, and make it easier for weak interfaces to persist unnoticed until a patient transfer or access request fails.

Failure mechanism: Custom or inconsistent exchange patterns break the assumption that every system will request, present, and export electronic health information in the same way, which increases the chance of blocked access, incomplete transfers, and control gaps around who can retrieve data.

Impact: Patients and clinicians may face delayed or inconsistent access, organisations may struggle to demonstrate compliant information sharing, and security teams may lose confidence that the interoperability layer is functioning as intended across all connected systems.

Practitioner Guidance

What to verify: Treat every nonstandard interface as a control exception. Verify whether the implementation preserves complete exportability, consistent user experience, and traceable access paths across the full patient journey, including transfers and system changes.

What good looks like: A good implementation behaves predictably across vendors and workflows, with the same data accessible through approved paths without manual workarounds, undocumented mappings, or case-by-case escalation.

Common mistake: Teams often evaluate interoperability only as an integration project. The more durable view is to evaluate it as a governance decision that can affect access, compliance posture, and operational resilience long after deployment.

Practitioner takeaway: If interoperability is not standardised, the hidden cost is usually not the interface itself but the uncertainty it creates around access, accountability, and continuity when the system must prove it can still move health information reliably.

Related resources from NHI Mgmt Group

• Why do decentralised data models create new access control risks for sensitive health information?
• How should healthcare organisations implement secure EMR access when expanding electronic health information exchange?
• Who is accountable for AI agent access to protected health information?
• What breaks when AWS access controls and logging are too weak for protected health information?